• OPEN AN ACCOUNT
Indian Indices
Sensex
78,168.44 -374.00
( -0.48%)
Global Indices
Nasdaq
53,996.18 -61.75
(-0.11%)
Dow Jones
7,774.29 -4.35
(-0.06%)
Hang Seng
66,870.65 1,263.94
(1.93%)
Nikkei 225
10,869.98 -31.11
(-0.29%)
Forex
USD-INR
95.15 -0.05
(-0.05%)
EUR-INR
109.97 0.14
(0.13%)
GBP-INR
128.34 0.21
(0.16%)
JPY-INR
0.60 0.00
(0.09%)

EQUITY - MARKET SCREENER

Sangani Hospitals Ltd
Industry :  Healthcare
BSE Code
ISIN Demat
Book Value()
79231
INE0OVI01010
27.9357029
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SANGANI
26.44
63.37
EPS(TTM)
Face Value()
Div & Yield %
1.74
10
0
 

mrf ltd
Concord Biotech's Unit II formulations unit successfully clears PPB and NDA inspection
Jun 25,2026
Concord Biotech announced the successful completion of inspection by the Pharmacy and Poisons Board (PPB) from Kenya and the National Drug Authority (NDA) from Uganda at Unit-II formulation facility. The inspection took place from 18 June 2026 to 24 June 2026, and was concluded successfully.